Your browser doesn't support javascript.
loading
Angiographic Features and Clinical Outcomes of Balloon Uncrossable Lesions during Chronic Total Occlusion Percutaneous Coronary Intervention.
Karacsonyi, Judit; Kostantinis, Spyridon; Simsek, Bahadir; Rempakos, Athanasios; Allana, Salman S; Alaswad, Khaldoon; Krestyaninov, Oleg; Khatri, Jaikirshan; Poommipanit, Paul; Jaffer, Farouc A; Choi, James; Patel, Mitul; Gorgulu, Sevket; Koutouzis, Michalis; Tsiafoutis, Ioannis; Sheikh, Abdul M; ElGuindy, Ahmed; Elbarouni, Basem; Patel, Taral; Jefferson, Brian; Wollmuth, Jason R; Yeh, Robert; Karmpaliotis, Dimitrios; Kirtane, Ajay J; McEntegart, Margaret B; Masoumi, Amirali; Davies, Rhian; Rangan, Bavana V; Mastrodemos, Olga C; Doshi, Darshan; Sandoval, Yader; Basir, Mir B; Megaly, Michael S; Ungi, Imre; Abi Rafeh, Nidal; Goktekin, Omer; Brilakis, Emmanouil S.
Affiliation
  • Karacsonyi J; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Kostantinis S; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Simsek B; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Rempakos A; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Allana SS; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Alaswad K; Department of Cardiology, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Krestyaninov O; Meshalkin Novosibirsk Research Institute, Novosibirsk 630055, Russia.
  • Khatri J; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Poommipanit P; Cardiology, Case Western Reserve University, University Hospitals, Cleveland, OH 44610, USA.
  • Jaffer FA; Department of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Choi J; Department of Cardiology, Baylor Heart and Vascular Hospital, Dallas, TX 75226, USA.
  • Patel M; Cardiovascular Institute, University of California San Diego, VA San Diego Healthcare System, La Jolla, CA 92037, USA.
  • Gorgulu S; Department of Cardiology, Biruni University School of Medicine, Istanbul 34295, Turkey.
  • Koutouzis M; First Cardiology Department Athens, Red Cross Hospital of Athens, Athens 11526, Greece.
  • Tsiafoutis I; First Cardiology Department Athens, Red Cross Hospital of Athens, Athens 11526, Greece.
  • Sheikh AM; Interventional Cardiology Department, Wellstar Health System, Marietta, GA 30141, USA.
  • ElGuindy A; Aswan Heart Centre, Department of Cardiology, Magdi Yacoub Foundation, Aswan 4271185, Egypt.
  • Elbarouni B; Department of Internal Medicine, St. Boniface General Hospital, Winnipeg, MB R2H 2A6, Canada.
  • Patel T; Interventional Cardiology, Tristar Centennial Medical Center, Nashville, TN 37203, USA.
  • Jefferson B; Interventional Cardiology, Tristar Centennial Medical Center, Nashville, TN 37203, USA.
  • Wollmuth JR; Interventional Cardiology, Providence Heart institute, Portland, OR 97213, USA.
  • Yeh R; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
  • Karmpaliotis D; Interventional Cardiology, Morristown Medical Center, Gagnon Cardiovascular Institute, Morristown, NJ 07960, USA.
  • Kirtane AJ; Division of Cardiology, Columbia University, New York, NY 10032, USA.
  • McEntegart MB; Division of Cardiology, Columbia University, New York, NY 10032, USA.
  • Masoumi A; Interventional Cardiology, Morristown Medical Center, Gagnon Cardiovascular Institute, Morristown, NJ 07960, USA.
  • Davies R; Interventional Cardiology, WellSpan York Hospital, York, PA 17403, USA.
  • Rangan BV; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Mastrodemos OC; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Doshi D; Department of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Sandoval Y; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
  • Basir MB; Department of Cardiology, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Megaly MS; Department of Cardiology, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Ungi I; Division of Invasive Cardiology, Department of Internal Medicine and Cardiology Center, University of Szeged, 6725 Szeged, Hungary.
  • Abi Rafeh N; Cardiology, North Oaks Health System, Hammond, LA 70403, USA.
  • Goktekin O; Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul 34676, Turkey.
  • Brilakis ES; Center for Coronary Artery Disease, Abbott Northwestern Hospital, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.
J Pers Med ; 13(3)2023 Mar 13.
Article de En | MEDLINE | ID: mdl-36983697
ABSTRACT

Background:

Balloon uncrossable lesions are defined as lesions that cannot be crossed with a balloon after successful guidewire crossing.

Methods:

We analyzed the association between balloon uncrossable lesions and procedural outcomes of 8671 chronic total occlusions (CTOs) percutaneous coronary interventions (PCIs) performed between 2012 and 2022 at 41 centers.

Results:

The prevalence of balloon uncrossable lesions was 9.2%. The mean patient age was 64.2 ± 10 years and 80% were men. Patients with balloon uncrossable lesions were older (67.3 ± 9 vs. 63.9 ± 10, p < 0.001) and more likely to have prior coronary artery bypass graft surgery (40% vs. 25%, p < 0.001) and diabetes mellitus (50% vs. 42%, p < 0.001) compared with patients who had balloon crossable lesions. In-stent restenosis (23% vs. 16%. p < 0.001), moderate/severe calcification (68% vs. 40%, p < 0.001), and moderate/severe proximal vessel tortuosity (36% vs. 25%, p < 0.001) were more common in balloon uncrossable lesions. Procedure time (132 (90, 197) vs. 109 (71, 160) min, p < 0.001) was longer and the air kerma radiation dose (2.55 (1.41, 4.23) vs. 1.97 (1.10, 3.40) min, p < 0.001) was higher in balloon uncrossable lesions, while these lesions displayed lower technical (91% vs. 99%, p < 0.001) and procedural (88% vs. 96%, p < 0.001) success rates and higher major adverse cardiac event (MACE) rates (3.14% vs. 1.49%, p < 0.001). Several techniques were required for balloon uncrossable lesions.

Conclusion:

In a contemporary, multicenter registry, 9.2% of the successfully crossed CTOs were initially balloon uncrossable. Balloon uncrossable lesions exhibited lower technical and procedural success rates and a higher risk of complications compared with balloon crossable lesions.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: J Pers Med Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: J Pers Med Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique